AbGenomics Corporation Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8/20/2012 10:52:54 AM
More...
|
AbGenomics Corporation Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
8/20/2012 10:51:20 AM
More...
|
AbGenomics Corporation Regains Global Rights to AbGn-168H from Boehringer Ingelheim Corporation
12/19/2011 6:30:52 AM
More...
|
Crucell N.V. (CRXL) And DSM Biologics Announce PER.C6(R) License Agreement With AbGenomics Corporation
1/11/2007 4:11:46 PM
More...
|
Boehringer Ingelheim GmbH And AbGenomics Corporation Sign Worldwide Exclusive Collaboration And License Agreement To develop And Commercialize A Therapeutic Monoclonal Antibody
10/19/2005 5:09:20 PM
More...
|